Research and Markets: Global Breast Cancer Drugs Market 2011-2015: The Global Breast Cancer Drugs Market to Grow at a …

Posted: Published on August 13th, 2012

This post was added by Dr P. Richardson

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/rs7g34/global_breast_canc) has announced the addition of the "Global Breast Cancer Drugs Market 2011-2015" report to their offering.

One of the key factors contributing to this market growth is the increasing prevalence of breast cancer worldwide. The Global Breast Cancer Drugs market has also been witnessing the trend of the emergence of combination therapies to treat breast cancer effectively. However, the availability of alternative treatment methods could pose a challenge to the growth of this market.

Key vendors dominating this market space include AstraZeneca plc, Novartis, Roche Pharmaceuticals, and Sanofi S.A. Other vendors mentioned in the report: Eli Lilly and Co. and GlaxoSmithKline plc.

Commenting on the report, an analyst from TechNavio's Healthcare team said; The current trend witnessed by the Global Breast Cancer Drugs market is combination therapy being used to treat breast cancer. Many oncologists believe that chemotherapy drugs are most effective when given in combination with radiation therapy and surgery. Cancer cells that are confined locally can be easily treated by surgery or radiation therapy, while cancer cells that have spread to distant sites in the body can be killed by chemotherapy. Therefore, combination therapy helps in completely removing the tumor or destroying the cancerous cells in the patient's body. The combination therapy is decided on depending on the size of the tumor and the risk of recurrence.

According to the report, globally, there has been an increase in the number of women being diagnosed with breast cancer. The increase in the incidence of breast cancer is due to a variety of factors such as obesity, excessive drinking of alcohol, and lack of exercise. Thus, with the increase in the prevalence of breast cancer, the demand for breast cancer drugs is also increasing.

Further, the report also discusses that the key challenge being confronted by the Global Breast Cancer Drugs market is the presence of alternative treatments for breast cancer.

For more information visit http://www.researchandmarkets.com/research/rs7g34/global_breast_canc

Read more:
Research and Markets: Global Breast Cancer Drugs Market 2011-2015: The Global Breast Cancer Drugs Market to Grow at a ...

Related Posts
This entry was posted in Drugs. Bookmark the permalink.

Comments are closed.